Attached files
| file | filename |
|---|---|
| S-1 - REGISTRATION STATEMENT - Tonix Pharmaceuticals Holding Corp. | v310591_s1.htm |
| EX-5.01 - EXHIBIT 5.01 - Tonix Pharmaceuticals Holding Corp. | v310591_ex5-01.htm |
Exhibit 23.01
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated March 30, 2012, in the Registration Statement (Form S-1) and related Prospectus of Tonix Pharmaceuticals Holding Corp. for the registration of up to 14,543,807 shares of its common stock.
/s/ EISNERAMPHER LLP
New York, New York
April 26, 2012